Board of Directors

Board of Directors

Drawing on broad industry expertise, our Board of Directors provides strategic oversight and guidance to support our long-term growth and mission

Chief Executive Officer

Jeremie Trochu

Jeremie joined Ardena as Chief Executive Officer in 2024.

 

He brings an extensive knowledge of the life sciences and CDMO industry, and a proven track record of success in the biopharma sector, with 20 years of experience building and growing businesses globally, expending into new markets, and leading large-scale transformations in both publicly traded and privately held companies.

 

Jeremie was previously part of the team that helped transform Catalent from a private equity spinoff into a publicly traded global CDMO, and during his tenure there, led the successful acquisition and integration of multiple companies.

 

 

Jeremie Trochu
Read full bio

Jeremie Trochu

Jeremie joined Ardena as Chief Executive Officer in 2024.   He brings an extensive knowledge of the life sciences and CDMO industry, and a proven track record of success in the biopharma sector, with 20 years of experience building and growing businesses globally, expending into new markets, and leading large-scale transformations in both publicly traded and privately held companies.   Jeremie was previously part of the team that helped transform Catalent from a private equity spinoff into a publicly traded global CDMO, and during his tenure there, led the successful acquisition and integration of multiple companies. He holds a Masters degree in Business Administration from EMLyon, France.
Non-Executive Chairman

Alan MacKay

Alan has over 30 years private equity experience, witrh a strong track record of dedicated healthcare investing.

 

Alan is currently a member of the board at Ardena, Sterling, Alcami, RoslinCT, and X-Chem and previously Quotient Sciences until its successful exit.

 

Previously, Alan was a board member at 3i plc, led the build-out of the 3i Europe office network, and founded 3i’s healthcare sector team as Global Head of Healthcare. Subsequently, Alan was founder, CEO and Chairman of the Investment Committee at Hermes GPE, an active co-investor in private equity-backed healthcare.

 

 

Alan MacKay
Read full bio

Alan MacKay

Alan has over 30 years private equity investment experience, with a strong track record of dedicated healthcare investing.

He is currently a member of the board at Ardena, Alcami, RoslinCT, X-Chem, and Sterling and previously Quotient Sciences until its successful exit.

Previously, Alan was a board member at 3i plc, led the build-out of the 3i Europe office network, and founded 3i’s healthcare sector team as Global Head of Healthcare. Subsequently, Alan was founder, CEO and Chairman of the Investment Committee at Hermes GPE, an active co-investor in private equity-backed healthcare.

Alan holds a Bachelor’s degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He was Chair of the BVCA and for a number of years chaired the BVCA Responsible Investment Advisory Board, and is currently Chairman of the European Healthcare Investors Association (EHIA).

Non-Executive Director

Sabina Ouimet-Storrs

Sabina is an investment professional with a background in both accounting and corporate finance.

 

Having joined GHO in 2015, Sabina currently works closely with Ardena and DDC, as well as previously with Caprion Biosciences prior to GHO Capital’s successful exit.

 

Prior to GHO, Sabina was with 123Venture in Paris where she was responsible for evaluating and executing mezzanine financing opportunities across Europe.

 

 

Sabina Ouimet-Storrs
Read full bio

Sabina Ouimet-Storrs

Sabina is an investment professional with a background in both accounting and corporate finance.   Having joined GHO in 2015, Sabina currently works closely with Ardena and DDC, as well as previously with Caprion Biosciences prior to GHO Capital’s successful exit.   Prior to GHO, Sabina was with 123Venture in Paris where she was responsible for evaluating and executing mezzanine financing opportunities across Europe. Before 123Venture, Sabina was with Fulcrum Capital Partners in Toronto, focusing on mid-market private equity and mezzanine financing opportunities across a broad range of sectors, having started her career and qualified as a chartered accountant in the audit and corporate finance teams at PwC in Toronto.   Sabina graduated from Dalhousie University in Canada and holds a Bachelor of Commerce with a major in Accounting.
Independent Director 

Ariette van Strien

Ariette brings over 30 years of experience in clinical research and global healthcare logistics to Ardena’s Board of Directors. She currently serves as President of UPS Healthcare Precision Logistics, where she leads a global team of 4,000 employees across 220+ countries and territories.

 

Throughout her career, Ariette has held senior executive roles spanning global marketing and business development, pricing, project management, and operations.

 

 

Ariette van Strien
Read full bio

Ariette van Strien

Ariette brings over 30 years of experience in clinical research and global healthcare logistics to Ardena’s Board of Directors. She currently serves as President of UPS Healthcare Precision Logistics, where she leads a global team of 4,000 employees across 220+ countries and territories.   Throughout her career, Ariette has held senior executive roles spanning global marketing and business development, pricing, project management, and operations. Her deep expertise in the pharmaceutical and CRO industries provides her with exceptional insights into the complexities of drug research, development, commercialization, and supply chain logistics.   Since joining legacy Marken in 2010, she has helped to position Marken as the market leader in clinical trials, advanced therapy, direct-to-patient and home healthcare, and developed optimized solutions and new service offerings for Marken’s clients.   Ariette earned a diploma as a National Public Relations Consultant, a Baccalaureate of Modern Languages and Biological Sciences, and a Superior French Language degree from the International College of Cannes, France.

Your molecule, your journey, our mission.

Get in touch to see how we can craft your path to the clinic with dedicated capabilities.